首页> 外文期刊>Case Reports in Oncology >A Case Report of Ischemic Stroke in a Patient with Metastatic Gastric Cancer Secondary to Treatment with the Vascular Endothelial Growth Factor Receptor-2 Inhibitor Ramucirumab
【24h】

A Case Report of Ischemic Stroke in a Patient with Metastatic Gastric Cancer Secondary to Treatment with the Vascular Endothelial Growth Factor Receptor-2 Inhibitor Ramucirumab

机译:血管内皮生长因子受体2抑制剂雷米库单抗治疗继发转移性胃癌患者缺血性中风的一例报道

获取原文
           

摘要

Ramucirumab is an antiangiogenesis agent targeting the vascular endothelial growth factor receptor-2 (VEGFR-2), approved to treat advanced gastric and colon cancer. In clinical trials, it was shown to cause a small increase in arterial thromboembolism com
机译:雷米库单抗是靶向血管内皮生长因子受体2(VEGFR-2)的抗血管生成剂,已被批准用于治疗晚期胃癌和结肠癌。在临床试验中,它被证明会导致动脉血栓栓塞症的微小增加

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号